Pharmiva AB (publ)

OM:PHARM Stock Report

Market Cap: SEK 9.7m

Pharmiva Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Anna Linton

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownership0.4%
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO

Anna Linton (52 yo)

1.3yrs

Tenure

Ms. Anna Linton is Chief Executive Officer of Pharmiva AB (publ) from August 2022. she has several years of experience in the development, commercialization and distribution of pharmaceuticals. During the...

Board Members

NamePositionTenureCompensationOwnership
Ulf Blom
Independent Director3.8yrsno datano data
Ingrid Heiman
Independent Director3.8yrsno datano data
Malte Zaunders
Chairman of the Board8.8yrsno datano data
Kristina Ingvar
Independent Director3.8yrsno datano data

3.8yrs

Average Tenure

54.5yo

Average Age

Experienced Board: PHARM's board of directors are considered experienced (3.8 years average tenure).